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The Stigma of Migraine
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Abstract
Background: People who have a disease often experience stigma, a socially and culturally embedded process through
which individuals experience stereotyping, devaluation, and discrimination. Stigma has great impact on quality of life,
behavior, and life chances. We do not know whether or not migraine is stigmatizing.
Methods: We studied 123 episodic migraine patients, 123 chronic migraine patients, and 62 epilepsy patients in a clinical
setting to investigate the extent to which stigma attaches to migraine, using epilepsy as a comparison. We used the stigma
scale for chronic illness, a 24-item questionnaire suitable for studying chronic neurologic diseases, and various disease
impact measures.
Results: Patients with chronic migraine had higher scores (54.0620.2) on the stigma scale for chronic illness than either
episodic migraine (41.7614.8) or epilepsy patients (44.6616.3) (p,0.001). Subjects with migraine reported greater inability
to work than epilepsy subjects. Stigma correlated most strongly with the mental component score of the short form of the
medical outcomes health survey (SF-12), then with ability to work and migraine disability score for chronic and episodic
migraine and the Liverpool impact on epilepsy scale for epilepsy. Analysis of covariance showed adjusted scores for the
stigma scale for chronic illness were similar for chronic migraine (49.3; 95% confidence interval, 46.2 to 52.4) and epilepsy
(46.5; 95% confidence interval, 41.6 to 51.6), and lower for episodic migraine (43.7; 95% confidence interval, 40.9 to 46.6).
Ability to work was the strongest predictor of stigma as measured by the stigma scale for chronic illness.
Conclusion: In our model, adjusted stigma was similar for chronic migraine and epilepsy, which were greater than for
episodic migraine. Stigma correlated most strongly with inability to work, and was greater for chronic migraine than
epilepsy or episodic migraine because chronic migraine patients had less ability to work.
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Introduction
Stigma is an established construct in the social sciences that
describes a characteristic, trait, or diagnosis that discredits
individuals and elicits prejudice, discrimination, and loss of status.
Goffman characterized stigma as a process that spoils the identity
of the stigmatized individual [1]. Many diseases, such as HIV,
depression, and epilepsy, are known to be stigmatizing and result
in disruption of social relationships, decreased quality of life, and
loss of employment [2–4]. While being stigmatized is in itself a
negative consequence of disease, it also has health implications,
because it affects the way individuals experiencing stigma seek and
access medical care, and because the lack of social belonging is
stressful and incurs negative health outcomes [5–7].
Stigma attaches to disease to varying degrees and in various
ways. Stigma can be ‘‘enacted,’’ as when individuals actually
experience discrimination, for example, through the loss of a social
relationship or employment. Stigma may also be ‘‘internalized’’ or
perceived, which refers to individual’s own feelings about their
condition, including anticipation about how others might react to
it [8]. Subjective experiences of stigma can be as damaging to
health as acts of discrimination and the actual loss of social
relationships [9]. Although many claim that migraine is stigma-
tizing, to date there has been only one study on stigma in people
with migraine [10]. In our study we measure how much stigma
migraine patients experience in comparison to epilepsy patients–a
group that has been studied extensively [11].
Methods
Study Population
Between October 2009 and July 2011, we recruited patients
with migraine or epilepsy from the Jefferson Headache Center and
the Jefferson Comprehensive Epilepsy Center in Philadelphia,
Pennsylvania. Questionnaires were administered in an office
setting. Inclusion criteria were subjects between the ages of 18–
65, who had migraine or epilepsy diagnosed by a specialist.
Exclusion criteria were inability to give accurate responses and a
diagnosis of epilepsy and severe episodic migraine (EM) or chronic
migraine (CM). Migraine is a primary headache disorder with
attacks lasting 4 to 72 hours untreated and at least two of the
following features: severe pain, unilaterality, throbbing, or
exacerbation with activity; and one of the following features:
nausea or light and sound sensitivity. The migraine type was
determined by an attending physician who was board certified in
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headache medicine, following criteria set forth in the International
Classification of Headache Disorders [12]. If the number of
headache days per month is greater than 14, and eight of these
headache days met criteria for migraine (or would if not treated),
then the person had CM. If the number of headache days per
month is 14 or less, then the person had EM.
The institutional review board at Thomas Jefferson University
Hospital reviewed and approved this study, and written informed
consent was obtained from each participant.
Questionnaire Administration
Both migraine and epilepsy patients completed a demographic
questionnaire, the stigma scale for chronic illness (SSCI), and the
short form of the medical outcomes health survey (SF-12). They
also completed a rankable series of questions on their actual or
potential (if they should try to get a job) disability. Migraine
patients completed the migraine disability score (MIDAS) and
answered a rankable series of questions on the degree of resting
necessitated by their headaches, and epilepsy patients completed
the Liverpool impact of epilepsy scale.
Stigma Scale for Chronic Illness (SSCI)
The SSCI is a 24-item questionnaire that quantifies the degree
and impact of stigma in patients with chronic illnesses. Thirteen
items measure ‘‘self/internalized stigma,’’ asking, for example,
whether the subject feels a sense of shame or anxiety about their
condition (SSCI-I) and 11 measure ‘‘enacted stigma,’’ asking, for
example, about instances of actual discrimination (SSCI-E)
[13,14].
SF-12 Health Survey
The SF-12 is a subset of the SF-36 quality-of-life questionnaire
that is used for patient-based assessments of physical and mental
health.
MIDAS
The MIDAS is a brief questionnaire that is used to quantify the
disability of migraine over a 3-month period. The number of days
the patient had migraine in the last 90 days and the average
headache severity are also assessed.
Figure 1. Effect on Work. Results of questionnaire in which subjects were asked about whether they could work. If they were not working and not
trying to work they were asked to imagine trying to work with their current headache or epilepsy condition. Chronic migraine had worse ability to
function.
doi:10.1371/journal.pone.0054074.g001
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The Liverpool Impact of Epilepsy Scale
This scale is a 9-item component of the extensive Liverpool
Seizure Severity Scale that assesses patients’ perception of the
impact of epilepsy on work, activity, personal relationships, and
self-image.
Ability to Work Score
Subjects were asked about the impact migraine or epilepsy had
on their ability to work (and to assume they were trying to work if
they were homemakers, retired, or had given up trying to work)
using five ranked questions (the lowest level of function was chosen
if multiple responses were given) (Figure 1).
Need to Rest Score
Subjects with migraine were asked about their need to lie down
or rest. They were given seven possible answers (Figure 2) that
were ranked with the lowest level of function if multiple responses
were given.
Statistical Considerations
To detect a difference of 10 points in the SSCI score between
the more and less disabled halves of the EM and CM patients at a
0.05 significance level, assuming a standard deviation of 19.7
(based on previous data), a sample size of 62 was required [13].
Thus, 124 subjects were required for each group. To distinguish a
10-point difference in mean scores between Ep and CM patients, a
sample of 62 patients would be sufficient. Data were analyzed
using SPSS. Pearson correlations were used unless otherwise
specified.
Results
One hundred twenty-four EM and CM and 62 Ep patients
completed the study. One subject in each migraine group was
excluded due to incomplete data, other than income. Internal
consistency for the four scales, as assessed by Cronbach’s alpha,
achieved good levels. The coefficients for the four scales were 0.96,
0.74, 0.86, and 0.83 for SSCI, MIDAS, Liverpool Impact Scale,
and SF-12, respectively.
A higher percentage of EM and CM than Ep patients were
female. EM patients were slightly older and had more education
and higher incomes (Table 1). CM patients had more work-related
disability (or potential disability) than EM patients and Ep patients
(p,0.001 EM vs CM, and Ep vs CM, p=NS EM vs Ep Mann-
Whitney) (Figure 1). Headache severity was similar in migraine
patients (Table 2). Patients with CM had greater need to rest than
patients with EM (Figure 2). Of the 62 epilepsy patients, 21
Figure 2. Effect on Need to Rest. Distribution of answers to questionnaire on the effect of migraine on need to rest and spending time in bed.
Subjects with chronic migraine reported spending more time in bed and resting (p,0.001, Krushal-Wallis test).
doi:10.1371/journal.pone.0054074.g002
The Stigma of Migraine
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e54074
patients (33.9%) had a history of surgery (i.e., temporal lobectomy
or resection of the seizure foci), two patients (3.2%) had a history of
both surgery and vagus nerve stimulator insertion, one patient
(1.6%) had a history of vagus nerve stimulator insertion, and 38
patients (61.3%) did not have any history of surgery or vagus nerve
stimulation. Epilepsy was focal in 49 patients (79%), generalized in
nine (14.5%) and unspecified in four (6.5%). Forty-eight patients
(77.4%) did not report any generalized tonic-clonic seizures in the
past month, while 12 patients (19.4%) did. One-year seizure
frequencies (which included all types of seizures) were divided into
three groups; 25 patients were seizure-free (40.3%), 25 patients
(40.3%) had less than four seizures, and 10 (16.1%) patients had
more than four seizures.
CM patients experienced statistically significantly more stigma
than EM or Ep patients as measured by SSCI scores (Figure 3,
Table 2). We examined the ratio of internalized stigma to the total
stigma score, SSCI-I/SSCI, and found that a higher proportion of
the stigma reported by CM and EM patients could be attributed to
internalized stigma than enacted stigma (Table 2). The ratio of
SSCI-I to SSCI (total) did not vary by age or gender, but
correlated negatively with ability to work (r =20.201, p,0.001).
Functional and quality-of-life measurements were lower for CM
than EM (Table 2). SF-12 scores were lower for CM than EM or
Ep patients, and lower for EM than Ep patients on the physical
component subscale (PCS) but not the mental component subscale
(MCS) (Table 2).
Correlations
SSCI, SSCI-I, and SSCI-E were strongly correlated (SSCI with
SSCI-E, and SSCI-I; r = 0.904, and 0.963, and for SSCI-E with
SSCI-I r = 0.755, p,0.001 for all) and with similar correlations for
each disease group. In general, correlations for SSCI, SSCI-I, and
SSCI-E were similar. Therefore, we will present only correlations
with SSCI and indicate areas where results differed between SSCI-
I and SSCI-E (Table 3).
All three groups demonstrated no association of gender or race
on SSCI, although the groups were heavily white. Migraine groups
showed no effect of age, education, or income on SSCI. With
epilepsy only, SSCI correlated positively with age (r = 0.347,
p = 0.006) and negatively with education (Spearman’s r =20.346,
p = 0.008) and income (r =20.336, p =20.008). All groups had a
strong negative correlation between ability to work and SSCI
(r =20.511 (EM), r =20.497 (CM), r =20.475 (Ep), p,0.001 for
all). SSCI was negatively correlated with PCS (r =20.179
p= 0.047 (EM), r =20.429 p,0.001 (CM), and r =20.472
p,0.001 (Ep )) and MCS (r =20.592 p,0.001 (EM),
r =20.575 p,0.001 (CM) and r =20.581 p,0.001 (Ep)). Only
for EM did the SSCI-E not correlate with PCS (Table 3). In
migraine, disability (MIDAS) was correlated with SSCI for EM
Table 1. Basic Demographics.
Episodic
Migraine
(EM)
(n=123)
Chronic
Migraine
(CM)
(n=123)
Epilepsy
(Ep)
N=62 p Value
CM/EM
p
EM/Ep
P
CM/Ep
P
Age 44.7612.5 40.9612.2 38.4613.1 0.003* 0.054** 0.054** 0.004**
Gender NSu ,0.001u ,0.001u
Male 17.1% 15.4% 45.2%
Female 82.9% 84.6% 59.8%
Race 0.028{ 0.036{{ 0.008{{ NS{{
Caucasian 95.1% 87.8% 83.9%
African-American 4.1% 7.3% 6.5%
Other 0.8% 4.9% 6.5%
Education ,0.001{ 0.015{{ ,0.001{{ 0.009{{
High school 15.4% 17% 35.5%
Some college 12.2% 24.4% 21.0%
Associates 5.7% 8.9% 11.3%
Bachelors 31.7% 26.8% 17.7%
Graduate/Professional 35.0% 22.8% 14.5%
Household Income ,0.001{ ,0.001{{ ,0.001{{ 0.21{{
0–18.5000 5.7% 13.8% 21.0%
18,5005–35000 8.9% 11.4% 19.4%
35,000–55,000 9.8% 21.1% 14.5%
55,000–90,000 28.5% 31.7% 14.5%
.90,000 46.3% 20.3% 24.2%
N 122 121 58
* =ANOVA;
**multiple comparisons with Bonferroni adjustment.
u=Chi Square test.
{= Kruskal-Wallis;
{{=Mann-Whitney.
doi:10.1371/journal.pone.0054074.t001
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(r = 0.445) and for CM (0.405, p,0.001 for both). In Ep, impact
score correlated with SSCI Score (r = 0.527, p,0.001). MIDAS
and ability to work were only modestly correlated (r =20.366 for
EM, r =20.368 for CM, p,0.001 for both), indicating substantial
differences in what these variables measured.
In migraine, SSCI had a moderate negative correlation with
need to rest (Spearman’s r = 0.479, p,0.001 (EM) 0.400, p,0.001
(CM)). SSCI correlated with headache severity for EM (r = 0.205,
p = 0.023) and CM (r = 0.218, p= 0.015). SSCI-E did not correlate
with severity for EM (r = 0.033, p=NS), but did for CM
(r = 0.211, p = 0.019). Migraine frequency did not correlate with
SSCI for EM (r = 0.086, p =NS) but did for CM (r = 0.218,
p = 0.015).
Analysis of Covariance (ANCOVA)
A 2 (Gender) X 3 (Group: EM, CM, and Ep) ANCOVA was
conducted. The dependent variable was the SSCI score and the
covariates were: (a) age, (b) income, (c) ability to work, (d) physical
component score (SF12), and (e) education. Preliminary analyses
evaluating the homogeneity-of-slopes assumption indicated that
the relationships between the covariates and the dependent
variable did not differ significantly. Results indicated no statisti-
cally significant interaction effect or gender effect; however, there
was a significant group effect: F (2, 290) = 3.17, p = .043,
g2 = .021. Follow-up tests were conducted to evaluate pairwise
differences among these adjusted means. Based on the least
significant difference procedure, the adjusted mean for EM (43.7;
95% confidence interval, 40.9 to 46.6) differed significantly from
both CM (49.3; 95% confidence interval, 46.2 to 52.4) and Ep
(46.5; 95% confidence interval, 41.6 to 51.6). There were no
significant differences between CM and Ep. Ability to work
achieved a strong association with SSCI as measured by the g2
of.157. The only other significant covariant was PCS with a weak
g2 of.024.
Discussion
In this study we used the SSCI, a newly developed questionnaire
to assess stigma in multiple neurological illnesses. The SSCI was
developed as one element of a multiple site project to produce
relevant and psychometrically robust quality of life assessment
tools for adults and children. The SSCI is one of 13 tools resulting
from this project and is available as a 24-item questionnaire, as
well as an 8-item short form, which was not yet available when the
study was conducted. The 24-item scale has two subscales,
‘‘internalized’’ and ‘‘enacted’’. Stigma scores for Ep and EM were
consonant with those found in a panel of diverse neurological
patients whose SSCI scores averaged 42.7 (+/219.7). CM patients
reported much higher SSCI scores than either group (54.0+/
220.2). CM patients reported particularly high SSCI-I scores,
which suggests that, of the three groups, they are the most likely to
identify with the stereotypes and negative labels that attach to
migraine.
Our finding that CM patients reported more stigma than both
epilepsy patients and patients with EM contradicts that of Aydemir
et. al, who found that epilepsy patients felt more stigmatized than
migraine patients in a clinical sample in Turkey [10]. Methodo-
logical differences may explain these divergent findings. Aydemir
et. al did not differentiate between CM and EM, which, according
to our analysis, could affect stigma scores. In addition, they used a
three-item stigma scale that had not been validated for use across
disease groups. Finally, stigma is a process deeply embedded in
Table 2. Measurements of Stigma, Quality of Life, and Impact.
Episodic
Migraine
Chronic
Migraine Epilepsy p* value
CM/EM
p
CM/Ep
p
EM/Ep
p
Total SSCI score 41.7614.8
(Median: 36)
54.0620.2
(Median: 53)
44.6616.3
(Median: 42.5)
,0.001* ,0.001 0.002 NS
SSCI –I 26.1610.0
(Median: 24)
34.5612.9
(Median: 33)
26.769.7
(Median: 28)
,0.001* ,0.001 ,0.001 NS
SSCI –E 14.965.8
(Median: 13)
19.568.3
(Median: 17)
18.068.1
(Median: 14)
,0.001* ,0.001 ,0.001 NS
SSCI-I/SSCI Total 0.62260.003 0.63760.004 0.59860.005 ,0.001 NS ,0.001 0.049
SF-12
PCS 42.3168.5
(Median: 43)
37.168.1
(Median: 37)
47.669.4
(Median: 51)
,0.001* ,0.001 ,0.001 ,0.001
MCS 47.61610.2
(Median: 49)
39.4611.8
(Median: 37)
46.6611.9
(Median: 48)
,0.001* ,0.001 ,0.001 NS
Total MIDAS score 28.54638.7
(Median: 19)
86.5677.86
(Median: 60)
,0.001{
Headache frequency (per 90 days) 18.7613.3
(Median: 16)
55.2629.1
(Median: 60)
,0.001{
Severity (0–10 scale) 6.163.6
(Median: 6.0)
6.361.4
(Median: 6.0)
0.085{
Liverpool Impact 9.266.8
(Median: 8)
*ANOVA, Bonferroni correction for multiple comparisons;
{Mann-Whitney. Headache severity and frequency based on MIDAS questions 6 and 7.
Abbreviations: SCCI = stigma scale for chronic illness; SSCI-I = internalized stigma; SSCI-E = enacted stigma; SF-12 = short form 12 in the medical outcomes study
Quality of Life questionnaire; PCS =physical component subscale of SF-12; MCS=mental component subscale of SF-12; MIDAS =migraine disability scale; Liverpool
impact scale = component of the Liverpool seizure severity scale.
doi:10.1371/journal.pone.0054074.t002
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social and cultural norms, and stigma might attach differently to
epilepsy and migraine in Turkey than in the United States.
We observed a numerically greater SSCI-I than SSCI-E for the
migraine groups, so we created an exploratory variable, SSCI-I/
Total SSCI to assess internalized stigma as a proportion of the
overall stigma score. Although the mean ratio of each group
differed only slightly, the standard deviation was small and the
difference reached significance. Both CM and EM report higher
rates of internalized stigma as a proportion of their overall stigma
score than Ep. This suggests that migraine patients have a more
vigorous process of converting enacted stigma into internalized
stigma. Alternatively, migraine patients may be better able to
suppress enacted stigma by being more circumspect about
divulging their medical condition while experiencing the internal-
ized stigma commensurate with their illness severity [15].
Migraine patients reported equally high stigma scores across
age, income, and education. In contrast, for epilepsy patients,
younger age, higher education, and higher income correlated with
lower SSCI scores. This finding suggests that a cultural shift may
be underway and that education and anti-stigma efforts in epilepsy
are taking hold. Anti-stigma efforts have been more limited for
migraine.
Patients’ reports of the impact of their disease correlated with
SSCI scores for both migraine (as measured by MIDAS, ability to
work and need to rest) and epilepsy (as measured by the Liverpool
impact scale). The only exception to this was pain severity, which
correlated with SSCI for CM, but not for SSCI-E in EM. This
may indicate more reserve among patients with EM to handle
more severe headache pain, or it may suggest that experiencing
intermittent, severe head pain, as people with EM do, is less
stigmatizing, since it is more consistent with public perception of
normal migraine.
The mental component of the SF-12 was more highly correlated
with stigma than the physical component. In our analysis, we
elected to model the physical component score of the SF-12 as an
independent variable as it seems implausible that the physical
consequences of migraine or epilepsy were caused by stigma. A
more difficult choice was to view the MCS as an independent
Figure 3. Stigma Scores. Distribution of stigma scores for EM, CM, and Ep. Scores for CM are significantly higher than for EM or Ep. CM scores were
higher than SSCI scores of 42.7+/219.7 for an internet panel of diverse neurological patients used to validate the SSCI (p,0.001, z-test), while EM and
Ep were not.
doi:10.1371/journal.pone.0054074.g003
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Table 3. Correlations Between Scales.
Migraine Type SSCI-I SSCI-E
Ability
to work PCS12 MCS12
Total
MIDAS
Need
to rest
Total
Impact
Episodic (N=123) A Total SSCI p-value .965 .889 2.511 2.179 2.592 .445 2.464
Sig. (2-tailed) .000 .000 .000 .047 .000 .000 .000
SSCI int p-value .738 2.531 2.198 2.636 .471 2.498
Sig. (2-tailed) .000 .000 .028 .000 .000 .000
SSCI enact p-value 2.389 2.116 2.415 .324 2.324
Sig. (2-tailed) .000 .202 .000 .000 .000
Ability to work p-value .336 .328 2.366 .490
Sig. (2-tailed) .000 .000 .000 .000
PCS12 p-value 2.018 2.258 .281
Sig. (2-tailed) .845 .004 .002
MCS12 p-value 2.497 .427
Sig. (2-tailed) .000 .000
Total MIDAS p-value 2.407
Sig. (2-tailed) .000
Need to rest p-value
Sig. (2-tailed)
Chronic (N=123) B Total SSCI p-value .968 .919 2.497 2.429 2.575 .405 2.429
Sig. (2-tailed) .000 .000 .000 .000 .000 .000 .000
SSCI int p-value .789 2.511 2.412 2.616 .433 2.449
Sig. (2-tailed) .000 .000 .000 .000 .000 .000
SSCI enact p-value 2.408 2.398 2.434 .308 2.340
Sig. (2-tailed) .000 .000 .000 .001 .000
Ability to work p-value .469 .321 2.368 .577
Sig. (2-tailed) .000 .000 .000 .000
PCS12 p-value .022 2.349 .349
Sig. (2-tailed) .808 .000 .000
MCS12 p-value 2.332 .430
Sig. (2-tailed) .000 .000
Total MIDAS p-value 2.548
Sig. (2-tailed) .000
Need to rest p-value
Sig. (2-tailed)
Epilepsy (N=62) C Total SSCI p-value .932 .901 2.475 2.472 2.581 .527
Sig. (2-tailed) .000 .000 .000 .000 .000 .000
SSCI int p-value .684 .530
Sig. (2-tailed) .000 2.461 2.443 2.594 .000
SSCI enact p-value 2.407 2.423 2.461 .428
Sig. (2-tailed) .001 .001 .000 .001
Ability to work p-value .521 .362 2.452
Sig. (2-tailed) .000 .004 .000
PCS12 p-value .444 2.533
Sig. (2-tailed) .000 .000
MCS12 p-value 2.740
Sig. (2-tailed) .000
Total MIDAS p-value
Sig. (2-tailed)
Need to rest p-value
Sig. (2-tailed)
2-tailed Pearson correlation coefficients for variables associated with episodic (A) and chronic (B) migraine, and for epilepsy (C). The p-values are not adjusted for
multiple comparisons.
Abbreviations: SCCI = stigma scale for chronic illness; SSCI-I = internalized stigma; SSCI-E = enacted stigma; PCS = physical component subscale of SF-12; MCS=mental
component subscale of SF-12; MIDAS=migraine disability scale.
doi:10.1371/journal.pone.0054074.t003
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variable and exclude it from the analysis. This is consistent with
the proposition that the stigma itself causes the MCS change, and
seems more plausible than higher MCS causing stigma. This
assumption should be viewed with some skepticism as an increased
MCS as a result of migraine or its comorbidities could result in
increased stigma and elevation of the SSCI score.
In our model, once we accounted for all factors, CM and Ep
had similar stigma while EM had less. In other words, CM incurs
more stigma than Ep, but only because in our sample people with
CM experience more disability and are less able to work.
However, CM incurs more stigma than EM, even when all
factors are taken into account, perhaps because EM aligns best
with public perceptions of the disease. Although we were able to
find significant correlations, we were only able to account for a
modest amount of the variance, indicating that other factors not
considered here, including individual factors, such as resilience,
are likely important determinants of an individual’s experience of
stigma.
The study has several strengths. It is the largest study of stigma
in migraine; the first study of stigma in migraine that uses validated
scales, including the SSCI; and the first study of stigma in migraine
in the United States. In this case, the reliance on physician
diagnosis and chart notes for diagnosis is likely to be more accurate
than cross-sectional diagnostic interviews.
However, this study has several weaknesses. Generalizability
may be limited, as patients in this study were drawn from highly
specialized clinics. Also, many EM patients at the headache clinic
are likely to have had CM in the past, which would reduce
differences between groups. We did not differentiate between types
of epilepsy or account for the presence of migraine aura. We
lacked a validated ‘‘ability to work’’ scale that would apply to both
migraine and epilepsy, and would account for people who are
homemakers or have stopped trying to work. Our disability and
impact scales overlap in what they measure, however the
correlations between these scales were modest, indicating diversity
in what they measured. Other interesting data, such as duration of
illness, psychiatric co-morbidity, number of medications, and body
mass index, were not collected.
Stigma has important public health implications that ought to
be addressed [6]. As in epilepsy, we should undertake to reduce
the stigma of migraine. These interventions may take place at
multiple levels: by endeavoring to reduce stigma among the public
through education, advocacy, and legal and policy interventions;
at the organizational level, through training programs for
clinicians; and at the intrapersonal level, through counseling,
therapy, support, and empowerment programs [16].
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